Revelation Biosciences, Inc. (REVB)

NASDAQ: REVB · IEX Real-Time Price · USD

2.240

+0.090 (4.19%)

At close: Apr 18, 2024, 4:00 PM

2.190

-0.050 (-2.23%)

After-hours: Apr 18, 2024, 7:56 PM EDT

Revelation Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	4	3	4	145	93	-
Market Cap Growth	-	-29.53%	-96.92%	55.53%	-	-
Enterprise Value	-8	-9	-1	144	89	0
PE Ratio	-26.22	-26.22	-0.41	-12.11	-57.26	-
PB Ratio	0.55	0.47	4.25	-1459.95	27.37	-
P/FCF Ratio	-0.43	-0.43	-0.40	-12.94	-65.73	-
P/OCF Ratio	-0.43	-0.43	-0.40	-13.09	-65.73	-
EV/EBITDA Ratio	92.84	92.84	0.07	-12.08	-54.51	-
EV/EBIT Ratio	73.50	73.50	0.07	-12.01	-54.51	-
EV/FCF Ratio	1.21	1.21	0.07	-12.83	-62.57	-
Debt / Equity Ratio	-	-	-	-0.17	-	-2.75
Debt / EBITDA Ratio	-	-	-	0.00	-	-
Debt / FCF Ratio	-	-	-	0.00	-	-
Quick Ratio	2.15	2.15	1.18	0.60	3.72	0
Current Ratio	2.18	2.18	1.22	0.89	3.82	0.86
Return on Equity (ROE)	-1.30%	-1.30%	-3236.10%	704.80%	-95.70%	-
Return on Assets (ROA)	-0.80%	-0.80%	-178.70%	-30.80%	-70.20%	-
Return on Capital (ROIC)	-130.22%	-130.22%	-1032.30%	14447.26%	-4.26%	-
Earnings Yield	-3.29%	-3.81%	-242.04%	-8.25%	-1.75%	-
FCF Yield	-199.20%	-231.09%	-250.76%	-7.73%	-1.52%	-
Buyback Yield / Dilution	-215.00%	-215.00%	-672.10%	-309.63%	-	-
Total Shareholder Return	-215.00%	-215.00%	-672.10%	-309.63%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).